Health Canada has officially given the green light for the first phase of clinical trials involving transplantation of cord blood cells expanded with the small molecule UM171 for the treatment of blood-related cancers. Thanks to our collaborators at IRIC and Hôpital Maisonneuve-Rosemont
Visit the new Leucegene website. Several of our lab members are involved in this project.
The public has voted this scientific breakthrough 2014 Québec Science Discovery of the Year.
UPCOMING PRESENTATIONS BY GUY SAUVAGEAU AND LAB MEMBERS
October 24th 2023: Till and McCulloch meeting in Toronto
December 9th to 12th 2023: American society of hematology meeting in San Diego